Podcasts

Nuclear medicine has undergone extraordinary transformation over the past decades, and it continues to redefine how cancer is diagnosed and…

In this series, host Catherine Glass speaks with Lalith Wijedoru, founder of Behind Your Mask, London, UK, about why social connection is…

In this latest episode of Hema Now, we go behind the scenes of the EAHAD 2026 Congress, exploring how the programme is developed, key emerging priorities, and what lies ahead for haemophilia care in Europe.

In this podcast, listen to Laurent Peyrin-Biroulet’s insights into the latest data from the SEQUENCE trial, including implications for…

In the final podcast of this three-part series, we hear expert insights into evolving guidelines, practical tools, and multidisciplinary…

Learn more about regenerative hepatology in this series featuring Ludovic Vallier, an expert on the development of clinically relevant cell types from human pluripotent stem cells

In this podcast episode, leading respiratory experts discuss the importance of collecting robust local data to deliver real change to the…

Robin Jones reflects on his career and explores the complexities of sarcoma care, from diagnostic challenges to evolving treatments, unmet needs, and what the future may hold for patients.

Explore innovations shaping liver transplantation, from stem cell science and bioengineered tissues to leadership, equity, and translating discovery into clinical care.

Kenneth Anderson, leading haematology expert at Dana-Farber, shares insights on multiple myeloma, drug resistance, key ASH updates, and turning…

Chronic pain, particularly in the context of rheumatic diseases, represents one of the most pervasive global health challenges, affecting…

In this series, host Saranya Ravindran speaks with Stuart Elborn about translating science into practice. They explore pivotal CF trials, novel and…

Rob Jones of the University of Glasgow shares insights on clinical trial innovation, emerging cancer treatments, and the challenges of managing toxicity in oncology care.

In this series, host Catherine Glass speaks with Michael Byrne about the rise of AI in endoscopy, tackling bias, and redefining clinical trials.

In this special countdown episode, the EMJ Podcast team looks back at the 10 highest-performing episodes of 2025. Spanning neurology…

In this special two-part episode of Onc Now, Catherine Glass returns to take you through the incredible lineup of guests from 2025.

In this series, host Saranya is joined by Nicholas Simmonds to explore the evolving landscape of cystic fibrosis in adulthood.

In this special two-part Onc Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global oncology clinicians and researchers.

David Heymann, global health leader and professor of infectious disease epidemiology, shares lessons from Ebola, SARS, smallpox, and the future of pandemic preparedness.

In this special two-part Hema Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global hematology clinicians and researchers.

In this series, host Saranya Ravindran speaks with Lisa Saiman about the global threat of microbial infection and resistance in patients with cystic fibrosis.

Luis Querol discusses the importance of complement in innate immunity, and how its dysregulation can contribute to autoimmune neuromuscular…

Anna Minchom, Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital, explains the drug development process, key considerations in designing and conducting a trial, and the challenges in drug resistance.

In this series, host Catherine Glass speaks with Katharine Phillips to explore body dysmorphic disorder beyond the skin.